• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kalbe Farma Tbk PT

+ Add to Watchlist

LCLA:GR

0.110 EUR 0.001 0.92%

As of 03:09:37 ET on 09/19/2014.

Snapshot for Kalbe Farma Tbk PT (LCLA)

Open: 0.102 Day's Range: 0.102 - 0.114 Volume: 0
Previous Close: 0.109 52wk Range: 0.063 - 0.119 1-Yr Rtn: +42.65%

Stock Chart for LCLA

No chart data available.
  • LCLA:GR 0.110
  • 1D
  • 1M
  • 1Y
0.109
Interactive LCLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LCLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 36.1054
Relative P/E vs. DAX -
Earnings Per Share (IDR) (ttm) -
Est. EPS (IDR) (12/2014) 47.0190
Est. PEG Ratio 3.1506
Market Cap (M EUR) 5,156.26
Shares Outstanding (M) 46,875.12
30 Day Average Volume 2,503
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.96%
Cash Dividend (IDR) 17.0000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 42.80%
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LCLA

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for LCLA

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for LCLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil